Fluid Management in CKD Patients

Clinical Assessment and Decision Making

The European Society of Cardiology recommends assessing volume status through physical examination, including jugular venous pressure, peripheral edema, and pulmonary examination, to determine the need for diuretics or fluid administration in CKD patients with elevated BUN 1.
The American College of Cardiology suggests examining for signs of volume overload, such as elevated JVP, peripheral edema, and pulmonary congestion, to initiate diuretic therapy in CKD patients 2, 1.
The American College of Cardiology recommends examining for signs of hypovolemia, such as hypotension, poor skin turgor, and low JVP, to initiate fluid administration in CKD patients 1, 4.
Daily weight trends, with a weight gain of >2-3 kg suggesting fluid accumulation, can be used to assess volume status in CKD patients 1.

The American College of Cardiology recommends initiating diuretic therapy with loop diuretics, such as furosemide 20-80 mg, in CKD patients with volume overload 6, 2.
The American College of Cardiology suggests adding a thiazide-type diuretic, such as metolazone 2.5-5 mg, for synergistic effect in CKD patients with diuretic resistance 2, 3, 6.
The National Kidney Foundation recommends administering fluids, such as dextrose 5% solution, in CKD patients with hypovolemia, avoiding salt-containing solutions 4.

The American College of Cardiology recommends daily monitoring of fluid intake and output, body weight, JVP, and extent of edema in CKD patients during treatment 2, 3, 1.
The European Society of Cardiology suggests avoiding excessive blood pressure reduction and recognizing worsening azotemia during diuresis in CKD patients 3, 2.
The American College of Cardiology recommends not discharging patients prematurely and ensuring a stable diuretic regimen and euvolemia are achieved before discharge 2.